EATONTOWN, N.J., Aug. 18, 2020 /PRNewswire/ — Key Highlights: First AngelMed Guardian® patient implants in Asia Pacific for Hydrix Medical, a subsidiary of Hydrix Limited (ASX: HYD) Four implants were carried out under the guidance of leading Cardiologist Dr. Leslie Lam This significant milestone provides a foundation for future implants under early access schemes in Singapore and Australia Angel […]
Other News
Virginia Cardiovascular Specialists Deploys PatientKeeper to Enable Providers to Access Patient Records and Capture Charges on Mobile Devices
EHR optimization software streamlines workflow for physicians practicing at Richmond-area HCA Virginia and Bon Secours hospitals WALTHAM, Mass., and RICHMOND, Va., Aug. 18, 2020 /PRNewswire/ — Virginia Cardiovascular Specialists (VCS), a leading cardiology practice in Richmond, VA, has deployed PatientKeeper® to enable its providers to have immediate access to patient records and to enter professional charges, anytime, […]
Northwestern Medicine First in Illinois to Utilize Advanced Imaging System During Heart Rhythm Procedure
System reduces radiation exposure, provides 3D, high-definition images of heart in real time CHICAGO, Aug. 17, 2020 /PRNewswire/ — A Northwestern Medicine Bluhm Cardiovascular Institute physician was the first in Illinois to use a new advanced imaging system during cryoablation, a minimally-invasive treatment for atrial fibrillation requiring precise images of the heart. Bradley Knight, […]
Akcea and Ionis to Present Phase 2 Results of AKCEA-APOCIII-L(Rx) in Late-Breaking Presentation at ESC Congress 2020
Data presentation will highlight efficacy, safety and tolerability of investigational medicine in patients with hypertriglyceridemia and cardiovascular disease BOSTON and CARLSBAD, Calif., Aug. 18, 2020 /PRNewswire/ — Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), today announced that data from the Phase 2 study of AKCEA-APOCIII-LRx will be […]
Cytokinetics Announces Partnership to Improve Prediction of Risk and Outcomes in Hypertrophic Cardiomyopathy
Company Makes Long-term Commitment to Outcomes Research in HCM SOUTH SAN FRANCISCO, Calif., Aug. 18, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq:CYTK) today announced a $1 million grant and four-year partnership with the HCM Registry (HCMR), a global registry of patients with hypertrophic cardiomyopathy (HCM) focused on improving predictive measures […]
CHF Solutions’ Aquadex Products Granted Federal Supply Schedule Contract
EDEN PRAIRIE, Minn., Aug. 18, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, today announced that its Aquadex™ product line has been added to the Federal Supply Schedule, expanding access to all federal government agencies, […]
New Pilot Study Indicates Niagen® May Reduce Inflammatory Cytokines in Stage D Heart Failure Patients
Niagen® (patented nicotinamide riboside) may reduce production of inflammatory cytokines in pilot study of Stage D heart failure patients LOS ANGELES–(BUSINESS WIRE)–ChromaDex Corp. (NASDAQ:CDXC) today announced the 11th published human trial on its patented NAD-boosting nutrient Niagen®, further highlighting its potential to support cardiovascular health in humans. A NIH funded study […]
Foldax Named a Finalist in the Fierce Innovation Awards – Life Sciences Edition 2020
Tria Heart Valve Made with Proprietary LifePolymer Reimagines Material, Design and Manufacturing to Solve Long-Standing Heart Valve Issues SALT LAKE CITY–(BUSINESS WIRE)–Foldax® announced today that it has been selected as a finalist in the Fierce Innovation Awards – Life Sciences Edition 2020, a peer-reviewed awards program from the publisher of Fierce Biotech and Fierce Pharma, […]
Endospan Receives FDA IDE Approval to Initiate a Pivotal Study of the NEXUS™ Aortic Arch Stent Graft System
HERZLIA, Israel–(BUSINESS WIRE)–Endospan, a pioneer in off-the-shelf endovascular repair of aortic arch disease received approval from FDA of an investigational device exemption, or IDE, to start the TRIOMPHE study on the NEXUS™ Aortic Arch Stent Graft System (hereinafter referred to as NEXUSTM). Earlier this year, FDA granted NEXUSTM designation as a […]
American Society for Preventive Cardiology (ASPC) Announces Newly Elected President Peter P. Toth, MD, PhD, FASPC
JACKSONVILLE, Fla., Aug. 17, 2020 /PRNewswire/ — During the ASPC annual business meeting during the recent 2020 ASPC Virtual Summit on CVD Prevention, Peter P. Toth, MD, PhD, FASPC was officially elected as the President of the American Society for Preventive Cardiology (ASPC). ASPC is a national multidisciplinary membership organization dedicated to the prevention […]



